Clinical Trial Update: OPsumit USers Registry

View source ↗

Summary

The OPSUMIT USERS Registry, sponsored by Actelion, has a completed status for macitentan (Opsumit) in pulmonary arterial hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• OPSUMIT (macitentan)

Snippet

Sponsor: Actelion | Conditions: Pulmonary Arterial Hypertension | Status: COMPLETED